Class Actions Are A Growing Risk For CBD Cos.
The U.S. Food and Drug Administration and the Federal Trade Commission issued warning letters to various CBD manufacturers in 2019 alleging a number of violations, including unsubstantiated advertising claims, and marketing...To view the full article, register now.
Already a subscriber? Click here to view full article